New Key Statistics Module, Z-Score and F-Score
NAS:CRBP Key Ratios
Market Cap $ M | 484.97 |
Enterprise Value $ M | 389.64 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 4.92 |
Price/Sales | -- |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | -- |
EPS (TTM) $ | -6.94 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | -21.30 |
5-y EBITDA Growth Rate % | 26.90 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -10.30 |
EV-to-EBITDA | -10.47 |
PEG | -- |
Shares Outstanding M | 10.69 |
Net Margin (%) | -- |
Operating Margin % | -- |
Pre-tax Margin (%) | -- |
Quick Ratio | 4.69 |
Current Ratio | 4.69 |
ROA % (ttm) | -59.08 |
ROE % (ttm) | -145.06 |
ROIC % (ttm) | -189.46 |
Dividend Yield % | -- |
Altman Z-Score | -- |
CRBP Number of Guru Trades
CRBP Volume of Guru Trades
Gurus Latest Trades with NAS:CRBP
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:CRBP is held by these investors
Total 1
Corbus Pharmaceuticals Holdings Inc Insider Transactions
No Available Data
News about NAS:CRBP
Total 0- 1